Your browser doesn't support javascript.
loading
Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids.
Tian, Yu; Tsujisaka, Yuta; Li, Vanessa Y; Tani, Kanae; Lucena-Cacace, Antonio; Yoshida, Yoshinori.
Afiliação
  • Tian Y; Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Tsujisaka Y; Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Li VY; Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Tani K; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Lucena-Cacace A; Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
  • Yoshida Y; Wellesley College, Wellesley, MA, United States.
Front Cell Dev Biol ; 10: 1001453, 2022.
Article em En | MEDLINE | ID: mdl-36438566

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão